Suppr超能文献

冠状动脉疾病患者的个体化治疗:机器学习方法。

Personalized treatment for coronary artery disease patients: a machine learning approach.

机构信息

Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.

Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.

出版信息

Health Care Manag Sci. 2020 Dec;23(4):482-506. doi: 10.1007/s10729-020-09522-4. Epub 2020 Oct 10.

Abstract

Current clinical practice guidelines for managing Coronary Artery Disease (CAD) account for general cardiovascular risk factors. However, they do not present a framework that considers personalized patient-specific characteristics. Using the electronic health records of 21,460 patients, we created data-driven models for personalized CAD management that significantly improve health outcomes relative to the standard of care. We develop binary classifiers to detect whether a patient will experience an adverse event due to CAD within a 10-year time frame. Combining the patients' medical history and clinical examination results, we achieve 81.5% AUC. For each treatment, we also create a series of regression models that are based on different supervised machine learning algorithms. We are able to estimate with average R = 0.801 the outcome of interest; the time from diagnosis to a potential adverse event (TAE). Leveraging combinations of these models, we present ML4CAD, a novel personalized prescriptive algorithm. Considering the recommendations of multiple predictive models at once, the goal of ML4CAD is to identify for every patient the therapy with the best expected TAE using a voting mechanism. We evaluate its performance by measuring the prescription effectiveness and robustness under alternative ground truths. We show that our methodology improves the expected TAE upon the current baseline by 24.11%, increasing it from 4.56 to 5.66 years. The algorithm performs particularly well for the male (24.3% improvement) and Hispanic (58.41% improvement) subpopulations. Finally, we create an interactive interface, providing physicians with an intuitive, accurate, readily implementable, and effective tool.

摘要

目前管理冠状动脉疾病 (CAD) 的临床实践指南考虑了一般心血管风险因素,但没有提出考虑患者个体特征的框架。我们使用 21460 名患者的电子健康记录,为个性化 CAD 管理创建了数据驱动的模型,与标准护理相比,这些模型显著改善了健康结果。我们开发了二进制分类器来检测患者在 10 年内是否会因 CAD 而发生不良事件。通过结合患者的病史和临床检查结果,我们实现了 81.5%的 AUC。对于每种治疗方法,我们还根据不同的监督机器学习算法创建了一系列回归模型。我们能够以平均 R = 0.801 的比例估计感兴趣的结果,即从诊断到潜在不良事件 (TAE)的时间。利用这些模型的组合,我们提出了 ML4CAD,这是一种新的个性化处方算法。同时考虑多个预测模型的建议,ML4CAD 的目标是使用投票机制为每个患者确定最佳预期 TAE 的治疗方法。我们通过在替代真实情况下衡量处方的有效性和稳健性来评估其性能。我们表明,我们的方法将当前基线的预期 TAE 提高了 24.11%,从 4.56 年增加到 5.66 年。该算法在男性(24.3%的改善)和西班牙裔(58.41%的改善)亚组中的表现尤为出色。最后,我们创建了一个交互式界面,为医生提供了一个直观、准确、易于实施和有效的工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验